JPH0121123B2 - - Google Patents

Info

Publication number
JPH0121123B2
JPH0121123B2 JP8269079A JP8269079A JPH0121123B2 JP H0121123 B2 JPH0121123 B2 JP H0121123B2 JP 8269079 A JP8269079 A JP 8269079A JP 8269079 A JP8269079 A JP 8269079A JP H0121123 B2 JPH0121123 B2 JP H0121123B2
Authority
JP
Japan
Prior art keywords
copolymer
iodine
methyl acrylate
vinylpyrrolidone
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP8269079A
Other languages
Japanese (ja)
Other versions
JPS568057A (en
Inventor
Hiroshi Takahashi
Shinji Takai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Kasei Corp
Original Assignee
Mitsubishi Kasei Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Kasei Corp filed Critical Mitsubishi Kasei Corp
Priority to JP8269079A priority Critical patent/JPS568057A/en
Publication of JPS568057A publication Critical patent/JPS568057A/en
Publication of JPH0121123B2 publication Critical patent/JPH0121123B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明は殺菌性組成物に関するものである。詳
しくはヨウ素を含む固体状殺菌性組成物に関する
ものである。 従来、ポリビニルピロリドンとヨウ素を含む液
状の組成物が殺菌剤として有用なことは知られて
いる。また、ビニルピロリドンとジビニルベンゼ
ン等のコモノマーの共重合体とヨウ素を含む固体
状の組成物が殺菌剤として有用なことも知られて
いる。 一方、緊急用手術器具や人口臓器のコーテイン
グ用に、固体状殺菌性組成物が必要とされてい
る。この用途には固体であることが必要であり、
従来知られているものでは殺菌性やヨウ素の溶解
性の点で不満足である。 本発明者等は、これらの事情に鑑み鋭意研究し
た結果、本発明に到達した。 すなわち、本発明の要旨は、ビニルピロリドン
とアクリル酸メチルまたはメチルメタクリレート
の共重合体およびヨウ素を含む固体状殺菌性組成
物に存する。 以下に本発明を詳細に説明する。 本発明に係わる組成物の一つの成分である、ビ
ニルピロリドンとアクリル酸メチルまたはメチル
メタクリレートの共重合体中のビニルピロリドン
とアクリル酸メチルまたはメチルメタクリレート
のモル比は、通常10:〜90〜90:10、好ましくは
30:70〜70:30である。ビニルピロリドンの量が
少なすぎると、組成物中に含みうるヨウ素の量が
低下して殺菌性が不十分となるし、またビニルピ
ロリドンの量が多すぎても共重合体の強度が低下
したりするので、何れも好ましくない。また、こ
の共重合体の分子量は、固体としての物性がみた
される範囲であれば、とくに制限はない。 ヨウ素の量は、ビニルピロリドンとアクリル酸
メチルまたはメチルメタクリレートの共重合体中
のビニルピロリドンの量により変化するが、この
共重合体に対し0.1〜10%(重量)、好ましくは
0.5〜5%(重量)である。共重合体中のビニル
ピロリドンの量が多い場合にはヨウ素を多く含む
ことができる。何れにしても、ヨウ素の量は、共
重合体中への溶解度以下である。ヨウ素の量が少
なすぎると殺菌性が不十分となるし、ヨウ素の量
が多すぎても、共重合体への溶解度をこえ、組成
物が不均一となるので好ましくない。 本発明組成物は、勿論その目的の範囲内におい
て、他の成分を含んでいてもさしつかえない。 本発明に係わる組成物は、例えば以下に述べる
ようにして製造することができる。 先ず、ビニルピロリドンとアクリル酸メチルま
たはメチルメタクリレートの共重合体は、常法に
よりビニルピロリドンとアクリル酸メチルまたは
メチルメタクリレートを所定量混合し、ラジカル
開始剤を触媒として、溶液重合、乳化重合や懸濁
重合を行わせることにより、製造することができ
る。低分子量の分画を除きたい場合には、常法に
より溶媒精製を行えばよい。このビニルピロリド
ンとアクリル酸メチルまたはメチルメタクリレー
トの共重合体は、例えばアセトンやメチルエチル
ケトン等のケトン系の溶媒等に可溶性である。 ビニルピロリドンとアクリル酸メチルまたはメ
チルメタクリレートを共重合体とヨウ素を混合す
るには、例えばこの共重合体を前記の様な溶媒に
溶解させ、ヨウ素の溶液を滴下し、混合した後、
例えば水等の貧溶媒を添加すると、目的とする組
成物を沈殿として得ることができる。 得られた組成物は殺菌性があり、緊急用手術器
具や人工臓器のレコーデイング用として有用であ
り、優れた物性を有している。 以下に製造例および応用例を挙げて、本発明を
更に詳細に説明するが、本発明はその要旨を超え
ない限り、以下の実施例により限定を受けるもの
ではない。 製造例 1 ビニルピロリドン(モノマー)50gおよびアク
リル酸メチル(モノマー)50gを、500mlのアセ
トンに溶解し、重合開始剤(アゾビスイソブチロ
ニトル)1gをアセトン10mlに溶解して加え、窒
素気流中で60℃、5時間反応させる。この反応物
を、n−ヘキサン中に滴下して、不溶な共重合体
を彩取する。 この共重合体は、クロロホルム、テトラヒドロ
フランおよびエチルメチルケトンに対して無色透
明に溶け、水、アセトンに対しては不溶であつ
た。 別にヨウ素のエチルアルコール飽和溶液を準備
し、この中に上記のビニルピロリドン−アクリル
酸メチル共重合体を浸漬し、24時間後、水洗、乾
燥する。 元素分析(重量%) C H N I 分析値 58.26 7.52 3.99 3.58 製造例 2〜3 ビニルピロリドン25gおよびアクリル酸メチル
75gまたはビニルピロリドン75gおよびアクリル
酸メチル25gを原料とした他は製造例1と同様に
して、殺菌性組成物が得られた。 製造例 4〜6 製造例1〜3において、アクリル酸メチルをメ
チルメタクリレートに代えた他は同様にして、殺
菌性組成物が得られた。 応用例 殺菌性の試験 製造例1により得られたビニルピロリドン−ア
クリル酸メチル共重合体−ヨウ素組成物0.5gを
試験管中のブレイン ハート インフユ−ジヨン
ブロス(Brain heart infusion broth)培地10
mlに加え、スタフイロコツカス アウレス(JC
−1株)またはエシエリシア コリ(JC−2株)
を所定量を加え、37℃で18時間静置培養または振
とう培養した。また、振とう培養したものについ
ては、菌を再接種し、37℃で18時間静置培養し
た。結果は表1に示した。 なお、表中で+の記号は殺菌効果あり、−の記
号は殺菌効果なしの意味をそれぞれ表わす。
FIELD OF THE INVENTION The present invention relates to fungicidal compositions. More specifically, the present invention relates to a solid antiseptic composition containing iodine. It has been known that liquid compositions containing polyvinylpyrrolidone and iodine are useful as disinfectants. It is also known that solid compositions containing iodine and copolymers of vinylpyrrolidone and comonomers such as divinylbenzene are useful as fungicides. On the other hand, solid germicidal compositions are needed for coating emergency surgical instruments and artificial organs. This application requires a solid state,
Conventionally known products are unsatisfactory in terms of bactericidal properties and iodine solubility. In view of these circumstances, the present inventors conducted extensive research and arrived at the present invention. That is, the gist of the present invention resides in a solid fungicidal composition comprising a copolymer of vinylpyrrolidone and methyl acrylate or methyl methacrylate and iodine. The present invention will be explained in detail below. The molar ratio of vinylpyrrolidone and methyl acrylate or methyl methacrylate in the copolymer of vinylpyrrolidone and methyl acrylate or methyl methacrylate, which is one component of the composition according to the present invention, is usually 10: to 90 to 90: 10, preferably
It is from 30:70 to 70:30. If the amount of vinyl pyrrolidone is too small, the amount of iodine that can be contained in the composition will be reduced, resulting in insufficient bactericidal properties, and if the amount of vinyl pyrrolidone is too large, the strength of the copolymer may be reduced. Therefore, neither is preferable. Further, the molecular weight of this copolymer is not particularly limited as long as the physical properties as a solid are satisfied. The amount of iodine varies depending on the amount of vinylpyrrolidone in the copolymer of vinylpyrrolidone and methyl acrylate or methyl methacrylate, but is preferably 0.1 to 10% (by weight) of the copolymer.
It is 0.5-5% (weight). When the amount of vinylpyrrolidone in the copolymer is large, it can contain a large amount of iodine. In any event, the amount of iodine is below its solubility in the copolymer. If the amount of iodine is too small, the bactericidal properties will be insufficient, and if the amount of iodine is too large, the solubility in the copolymer will be exceeded and the composition will become non-uniform, which is not preferable. The composition of the present invention may of course contain other components within the scope of its purpose. The composition according to the present invention can be produced, for example, as described below. First, a copolymer of vinyl pyrrolidone and methyl acrylate or methyl methacrylate is prepared by mixing a predetermined amount of vinyl pyrrolidone and methyl acrylate or methyl methacrylate using a conventional method, and then carrying out solution polymerization, emulsion polymerization, or suspension using a radical initiator as a catalyst. It can be produced by polymerization. If it is desired to remove low molecular weight fractions, solvent purification may be performed by a conventional method. This copolymer of vinyl pyrrolidone and methyl acrylate or methyl methacrylate is soluble in, for example, ketone solvents such as acetone and methyl ethyl ketone. To mix a copolymer of vinyl pyrrolidone and methyl acrylate or methyl methacrylate with iodine, for example, dissolve this copolymer in the above-mentioned solvent, add a solution of iodine dropwise, and mix.
For example, by adding a poor solvent such as water, the desired composition can be obtained as a precipitate. The resulting composition has sterilizing properties, is useful for recording emergency surgical instruments and artificial organs, and has excellent physical properties. The present invention will be explained in more detail below with reference to production examples and application examples, but the present invention is not limited by the following examples unless it exceeds the gist thereof. Production Example 1 50 g of vinyl pyrrolidone (monomer) and 50 g of methyl acrylate (monomer) were dissolved in 500 ml of acetone, 1 g of polymerization initiator (azobisisobutyronitrile) was dissolved in 10 ml of acetone, and the mixture was dissolved in a nitrogen stream. Incubate at 60°C for 5 hours. This reaction product is dropped into n-hexane to remove the insoluble copolymer. This copolymer was colorless and transparent and soluble in chloroform, tetrahydrofuran and ethyl methyl ketone, and insoluble in water and acetone. Separately, a saturated solution of iodine in ethyl alcohol is prepared, and the above vinylpyrrolidone-methyl acrylate copolymer is immersed in this solution, and after 24 hours, it is washed with water and dried. Elemental analysis (wt%) C H N I analysis value 58.26 7.52 3.99 3.58 Production examples 2-3 Vinylpyrrolidone 25g and methyl acrylate
A bactericidal composition was obtained in the same manner as in Production Example 1, except that 75 g or 75 g of vinylpyrrolidone and 25 g of methyl acrylate were used as raw materials. Production Examples 4 to 6 Antibacterial compositions were obtained in the same manner as in Production Examples 1 to 3, except that methyl acrylate was replaced with methyl methacrylate. Application Example Sterilization Test 0.5 g of the vinylpyrrolidone-methyl acrylate copolymer-iodine composition obtained in Production Example 1 was placed in a test tube of Brain heart infusion broth medium (10 g).
In addition to ml, Staphylococcus aures (JC
-1 strain) or E. coli (JC-2 strain)
A predetermined amount of was added and cultured either statically or with shaking at 37°C for 18 hours. In addition, for those cultured with shaking, the bacteria were re-inoculated and cultured statically at 37°C for 18 hours. The results are shown in Table 1. In addition, in the table, the symbol + means that there is a bactericidal effect, and the symbol - means that there is no bactericidal effect.

【表】【table】

【表】【table】

Claims (1)

【特許請求の範囲】[Claims] 1 ビニルピロリドンとアクリル酸メチルまたは
メチルメタクリレートの共重合体およびヨウ素を
含む固体状殺菌性組成物。
1. A solid fungicidal composition containing a copolymer of vinylpyrrolidone and methyl acrylate or methyl methacrylate and iodine.
JP8269079A 1979-07-02 1979-07-02 Sterilizing composition Granted JPS568057A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP8269079A JPS568057A (en) 1979-07-02 1979-07-02 Sterilizing composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8269079A JPS568057A (en) 1979-07-02 1979-07-02 Sterilizing composition

Publications (2)

Publication Number Publication Date
JPS568057A JPS568057A (en) 1981-01-27
JPH0121123B2 true JPH0121123B2 (en) 1989-04-19

Family

ID=13781405

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8269079A Granted JPS568057A (en) 1979-07-02 1979-07-02 Sterilizing composition

Country Status (1)

Country Link
JP (1) JPS568057A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19843903A1 (en) * 1998-09-24 2000-03-30 Basf Ag Solid dosage form for prolonged slow release of e.g. drugs, plant treatment agents or food or feed additives, containing copolymer of N-vinyl-lactam and methyl methacrylate as binder
JP5485895B2 (en) * 2007-09-27 2014-05-07 ビーエーエスエフ ソシエタス・ヨーロピア Osmotic transfer enhancer

Also Published As

Publication number Publication date
JPS568057A (en) 1981-01-27

Similar Documents

Publication Publication Date Title
US4482680A (en) Quaternary ammonium group-containing polymers having antimicrobial activity
US5008093A (en) Anhydrous complexes of PVP and hydrogen peroxide
US4532128A (en) Quaternary ammonium group-containing polymers having antimicrobial activity
US5108742A (en) Anhydrous complexes of PVP and H2 O2
US5122370A (en) Method for treating acne vulgaris with a composition containing a stable, high purity, substantially anhydrous complex of PVP-H2 O.sub.2
US3914403A (en) Hair care preparations containing N-vinyl pyrrolidone homo- and copolymers and a quaternized copolymer of vinyl pyrrolidone
DE2531828A1 (en) HYDROPHILIC ACRYLAMIDOPOLYMERS
JPH02291867A (en) Filmplastic-emulsion containing iodine
DE1667534A1 (en) Hydrogen peroxide stabilized as a solid and the process for its production
KR20070063579A (en) Stabilisation of aqueous solutions of homopolymers and copolymers of n-vinylpyrrolidones
DE285404T1 (en) INSECTICIDE DELIVERY COMPOSITIONS AND METHOD FOR CONTROLLING AN INSECT POPULATION IN AN AQUEOUS ENVIRONMENT.
US5093472A (en) Removal of residual solvent from acrylic acid polymer
KR20200116134A (en) Branched poly (amino acid) antimicrobial agents and uses thereof
KR100225270B1 (en) Stable solid form antimicrobial compositions comprising 3-isothiazolones
US5242985A (en) Aqueous stable complex of a strongly swellable, moderately crosslinked polyvinylpyrrolidone and iodine
ES8203391A1 (en) Copolymers having bactericidal activity, process for the preparation thereof and pharmaceutical compositions therefrom
JPH0121123B2 (en)
EP0107277B1 (en) Pliable films of polymeric halogen complexes
EP0087473A1 (en) Quaternary ammonium group-containing polymers having antimicrobial activity
TW201638118A (en) A preparation method of water soluble antimicrobial polyacrylate silver salt
US3067089A (en) Polyether-halogen compositions
EP0090577B1 (en) Insoluble polymeric contact preservatives
JPH05201842A (en) Composition for oral cavity application
JP3583178B2 (en) Method for producing antibacterial agent and antibacterial agent
RU2220982C9 (en) Argakril - new antiseptic and haemostatic agent